Qube Research & Technologies (QRT)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.9M | Sell |
121,052
-2,425,986
| -95% | -$340M | 0.02% | 970 |
|
|
2025
Q4 | $313M | Sell |
2,547,038
-2,281,513
| -47% | -$277M | 0.32% | 43 |
|
|
2025
Q3 | $536M | Buy |
4,828,551
+69,976
| +1% | +$7.95M | 0.55% | 15 |
|
|
2025
Q2 | $528M | Buy |
4,758,575
+2,401,289
| +102% | +$256M | 0.54% | 14 |
|
|
2025
Q1 | $264M | Buy |
+2,357,286
| New | +$243M | 0.31% | 71 |
|
|
2024
Q3 | – | Sell |
-1,509,613
| Closed | -$115M | – | 3607 |
|
|
2024
Q2 | $104M | Sell |
1,509,613
-703,042
| -32% | -$46.9M | 0.16% | 145 |
|
|
2024
Q1 | $162M | Buy |
2,212,655
+1,508,607
| +214% | +$116M | 0.26% | 88 |
|
|
2023
Q4 | $57M | Sell |
704,048
-446,276
| -39% | -$34.7M | 0.11% | 232 |
|
|
2023
Q3 | $86.2M | Buy |
1,150,324
+428,583
| +59% | +$33M | 0.23% | 105 |
|
|
2023
Q2 | $55.6M | Buy |
721,741
+505,201
| +233% | +$40.3M | 0.2% | 132 |
|
|
2023
Q1 | $18M | Buy |
+216,540
| New | +$17.9M | 0.08% | 276 |
|
|
2022
Q4 | – | Sell |
-971,154
| Closed | -$59.9M | – | 2659 |
|
|
2022
Q3 | $59.9M | Buy |
971,154
+299,321
| +45% | +$18.9M | 0.36% | 51 |
|
|
2022
Q2 | $41.5M | Buy |
671,833
+99,164
| +17% | +$6.14M | 0.31% | 66 |
|
|
2022
Q1 | $34M | Sell |
572,669
-240,073
| -30% | -$15.3M | 0.29% | 68 |
|
|
2021
Q4 | $59M | Buy |
812,742
+761,375
| +1,482% | +$52.4M | 0.46% | 18 |
|
|
2021
Q3 | $3.59M | Sell |
51,367
-3,641
| -7% | -$256K | 0.05% | 513 |
|
|
2021
Q2 | $3.79M | Sell |
55,008
-38,801
| -41% | -$2.59M | 0.04% | 493 |
|
|
2021
Q1 | $6.06M | Buy |
93,809
+68,042
| +264% | +$4.39M | 0.1% | 263 |
|
|
2020
Q4 | $1.5M | Sell |
25,767
-396,671
| -94% | -$23.9M | 0.02% | 729 |
|
|
2020
Q3 | $26.7M | Buy |
+422,438
| New | +$29.3M | 0.38% | 43 |
|
|
2020
Q2 | – | Sell |
-52,287
| Closed | -$3.91M | – | 1815 |
|
|
2020
Q1 | $3.91M | Buy |
52,287
+8,259
| +19% | +$571K | 0.16% | 122 |
|
|
2019
Q4 | $2.86M | Buy |
44,028
+27,122
| +160% | +$1.77M | 0.09% | 263 |
|
|
2019
Q3 | $1.07M | Sell |
16,906
-14,719
| -47% | -$962K | 0.71% | 26 |
|
|
2019
Q2 | $2.14M | Sell |
31,625
-1,155
| -4% | -$76K | 0.51% | 44 |
|
|
2019
Q1 | $2.13M | Buy |
+32,780
| New | +$2.18M | 0.28% | 82 |
|
|
2018
Q4 | – | Sell |
-36,604
| Closed | -$2.83M | – | 528 |
|
|
2018
Q3 | $2.83M | Buy |
36,604
+27,826
| +317% | +$2.1M | 0.38% | 52 |
|
|
2018
Q2 | $622K | Sell |
8,778
-4
| -0% | -$282 | 0.39% | 50 |
|
|
2018
Q1 | $662K | Buy |
+8,782
| New | +$698K | 0.25% | 58 |
|
Other funds holding GILD
VCM
VPM
Qube Research & Technologies (QRT)'s GILD Position: Q1 2026 in Review
Qube Research & Technologies (QRT) reduced its Gilead Sciences (GILD) stake by 95% in Q1 2026, selling an estimated $340M and leaving 121,052 shares worth $16.9M. The position accounts for 0.02% of the portfolio, ranked #970.
Qube Research & Technologies (QRT) first reported a position in GILD in Q1 2018 and has held it in 28 quarters since. The position peaked at $536M in Q3 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Qube Research & Technologies (QRT) held 121,052 shares of Gilead Sciences worth $16.9M as of Q1 2026.
- Qube Research & Technologies (QRT) sold 2,425,986 Gilead Sciences shares in Q1 2026, an estimated $340M.
- Gilead Sciences made up 0.02% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #970 holding.
- Qube Research & Technologies (QRT) first reported a position in Gilead Sciences in Q1 2018 and has held it in 28 quarters since.
- Qube Research & Technologies (QRT)'s Gilead Sciences position peaked at $536M in Q3 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.